Aging Is a Powerful Risk Factor for Type 2 Diabetes Mellitus Independent of Body Mass Index

Dear Editor,

Approximately 422 million individuals have diabetes mellitus worldwide [1]. The most widely accepted risk factor for type 2 diabetes mellitus (T2DM), and the focus of much of the research attention, is excess body weight [2]. Age is also a risk factor for diabetes [3] and, consequently, some [4] but not all [5] practice guidelines incorporate an age threshold as an independent criterion for performing clinical diabetes screening. However, the degree to which aging impacts the risk of diabetes across the BMI spectrum, in particular the magnitude of the aging effect in those with a normal BMI in whom obesity is not a contributing factor, has not been well described. This provided rationale to revisit the dynamics of the effect of aging on T2DM as a function of BMI [6].

We examined the effect of age on the prevalence of T2DM within narrow BMI ranges, using the patient database registry at a large academic health system (the Research Patient Data registry [RPDR] of Partners HealthCare System). The Partners HealthCare institutional review board approved this study, and informed consent was waived. We included adult patients between the ages of 18–90 years with a BMI between 18.5 and 40 kg/m² who were seen within the health system between January 1, 2016, and December 31, 2016. The study population consisted of 296,824 patients, divided into groups based on age (18–19, 20–29, 30–39, 40–49, 50–59, 60–69, 70–79, and 80–90 years) and BMI (18.5–19.99, 20–21.99, 22–23.99, 24–25.99, 26–27.99, 28–29.99, 30–31.99, 32–33.99, 34–35.99, 36–37.99, and 38–40 kg/m²). We calculated the prevalence of T2DM within each age and BMI group, using ICD-10 diagnosis codes for T2DM. We found a significant increase in prevalence of T2DM with age (p < 0.0001 using log-linear Poisson regression), inclusive of BMI groups in the normal range (Fig. 1). The aging effect was particularly evident after 40 years of age, at which time there was a statistically significant inflection point (p < 0.0001, Poisson regression). As a consequence of the aging effect, individuals older than 70 with a normal BMI have a similar prevalence of T2DM relative to those in their 30s with a BMI at the high end of the obese range.

Much of the public health and research focus surrounding the diabetes epidemic has centered on modifiable risk attributable to a Western lifestyle and obesity. We hypothesized that the effect of age is an important and underappreciated risk factor for T2DM whose magnitude has been difficult to quantify. Our analysis of a large database registry allowed us to quantify the effect of age within narrow BMI ranges, thereby demonstrating a powerful and consistent effect of aging on prevalence of T2DM, even in individuals with a low-normal BMI. One limitation of our study is the utilization of an ICD-10 diagnosis code to identify T2DM cases, which may have resulted in both underreporting of T2DM cases and also overreporting, for example patients being classified as having T2DM but instead having an autoimmune cause of diabetes mellitus such as latent autoimmune diabetes in adults. A second limitation is that we did not control for additional covariates. We assumed, however, that our large population size inclusive of all individuals with a BMI between 18.5 and 40 kg/m² and the fact that we controlled for BMI, a key mediator of the effects of other potential factors influencing prevalence of T2DM, would minimize the effect of other covariates on our central observation of an aging effect across the BMI spectrum.

Although the prevalence of T2DM is increasing, predominantly due to excess weight [7], these data illustrate that (1) lowering the rates of obesity will not eliminate the incidence of T2DM, especially as the average life expectancy increases, and (2) T2DM is a heterogeneous syndrome. Indeed, our data suggest that aging may augment T2DM risk through pathophysiological mechanisms independent of obesity. This underscores the unmet need for further research on the mechanisms of the age-associated increase in the prevalence of T2DM, which may reveal novel avenues for therapeutic development. Finally, these data also provide important additional support for the recommendation to screen all patients above a given age threshold for T2DM and not only those who are overweight or obese [4].